Preview Mode Links will not work in preview mode

Outbreak News Interviews

Dec 30, 2018

The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.

On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.